Industry › Clinical Trials

Press Releases

亞太地區細胞與基因研究：Novotech 的增長速度比世界其它地區快 50%

Feb 04, 2023 07:00 HKT/SGT

아시아 태평양 지역 세포유전자 연구: 노보텍이 세계의 나머지 모든 기관들보다 50% 더 빠르게 성장

Feb 04, 2023 07:00 HKT/SGT

亚太地区细胞与基因研究：Novotech 的增长速度比世界其它地区快 50%

Feb 04, 2023 07:00 HKT/SGT

Asia Pacific Cell & Gene Research Growing 50% Faster than ROW

Feb 03, 2023 13:00 HKT/SGT

노보텍, 미국 기반의 의약품 개발 컨설팅 회사인 CBR 인터내셔널 인수

Jan 12, 2023 15:00 HKT/SGT

Novotech 收购美国药物开发咨询公司 CBR International

Jan 12, 2023 15:00 HKT/SGT

Novotech Acquires US-based Drug Development Consulting Firm, CBR International

Jan 12, 2023 15:00 HKT/SGT

Novotech 收购欧洲 CRO——加强全球运营

Jan 12, 2023 15:00 HKT/SGT

노보텍, 유럽 CRO 인수 - 글로벌 운영 강화

Jan 12, 2023 15:00 HKT/SGT

Novotech Acquires European CRO, Strengthens Global Operations

Jan 12, 2023 15:00 HKT/SGT

Novotech 收購美國藥物開發諮詢公司 CBR International

Jan 12, 2023 15:00 HKT/SGT

Novotech 收購歐洲 CRO——加強全球運營

Jan 12, 2023 15:00 HKT/SGT

아방스 클리니컬, GlobalReady 성공 축하　40개 이상의 생명공학 고객이 프로그램에 참여

Jan 12, 2023 07:00 HKT/SGT

Avance Clinical 慶祝GlobalReady成功　超過40家生物技術客戶進入計劃

Jan 12, 2023 07:00 HKT/SGT

Avance Clinical 庆祝GlobalReady成功　超过40家生物技术客户进入计划

Jan 12, 2023 07:00 HKT/SGT

HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study)

Jan 11, 2023 21:00 HKT/SGT

Avance Clinical Celebrates GlobalReady Success as 40 Biotechs Join Program

Jan 11, 2023 15:00 HKT/SGT

君聖泰HTD1801治療非酒精性脂肪性肝炎（NASH）的臨床IIb 期研究（CENTRICITY研究）完成首例患者給藥

Jan 11, 2023 08:01 HKT/SGT

君圣泰HTD1801治疗非酒精性脂肪性肝炎（NASH）的临床IIb 期研究（CENTRICITY研究）完成首例患者给药

Jan 11, 2023 08:00 HKT/SGT

HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations

Jan 05, 2023 18:00 HKT/SGT